Research Centre

Go back to current news

November 16 , 2021

Health Canada is seeking input from Canadians and key stakeholders on their draft of GUI-0043: "Risk classification guide of observations related to clinical trial inspections of human drugs".

Feedback will be collected between November 15, 2021 and December 14, 2021.  As Covenant Health is a Network of Networks (N2) member, you are encouraged to provide your feedback through the N2 mechanism to support Health Canada's structured approach and to facilitate collation of feedback.

Please follow these links to the GUI-0043 draft guidance document in English and French, and the following link to provide your comments/feedback: N2 Member Feedback.

Note: modified from N2 notice

For stakeholders external to N2, please access the Health Canada consult directly in English and French.

Search Research
News Archives

Name or keyword: 7